Sydney M. and Stella H. Schoenberg Professor of Medicine; Professor of Orthopaedic Surgery and Cell Biology and Physiology; Chief, Division of Bone and Mineral Diseases; Musculoskeletal Research Center; Washington University School of Medicine
Endocrinology
Dr. Roberto Civitelli, MD
|
|
Give Review
Doctor Roberto Civitelli, MD works in the field of Endocrinology. He received awards:"Elected Member", "Fuller Albright Award", "Kappa Delta Award" and "CMS Meaningful Use Stage 1 Certification". Roberto Civitelli, MD is also a published MD. He has 102 publication published. The most recent publication is: Age-related decline of bone mass and intestinal calcium absorption in normal males. Roberto Civitelli accepts Medicare payments and is listed with Medicare.gov.
Publications
- N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.
- p62 Is Required for Stem Cell/Progenitor Retention through Inhibition of IKK/NF-κB/Ccl4 Signaling at the Bone Marrow Macrophage-Osteoblast Niche.
- Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review.
- Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions With β-catenin.
- Embryonic ablation of osteoblast Smad4 interrupts matrix synthesis in response to canonical Wnt signaling and causes an osteogenesis-imperfecta-like phenoType.
- Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults.
- Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated With increased marker of bone resorption.
- Connexin43 modulates post-natal cortical bone modeling and mechano-responsiveness.
- Calcium and phosphate homeostasis: concerted interplay of new regulators.
- Connexin43 Deficiency reduces the sensitivity of cortical bone to the effects of muscle paralysis.
- Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling.
- Low-magnitude whole-body vibration does not enhance the anabolic skeletal effects of intermittent PTH in adult mice.
- One-year effects of vitamin D and Calcium supplementation on chronic periodontitis.
- N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms.
- Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling.
- Cross-sectional study of vitamin D and Calcium supplementation effects on chronic periodontitis.
- Alveolar bone measurement precision for phosphor-plate images.
- Patient satisfaction in postmenopausal women treated With a weekly bisphosphonate transitioned to once-monthly ibandronate.
- Calcium and vitamin D use among adults in periodontal disease maintenance programmes.
- Bone turnover in bone biopsies of patients With low-energy cortical fractures receiving bisphosphonates: a case series.
- Bone turnover markers: understanding their value in clinical trials and clinical practice.
- Connexin43 modulation of osteoblast/osteocyte apoptosis: a potential therapeutic target?
- Epidemiology of glucocorticoid-induced Osteoporosis.
- Cell-cell communication in the osteoblast/osteocyte lineage.
- Attenuated response to in vivo mechanical loading in mice With conditional osteoblast ablation of the connexin43 gene (Gja1).
- Efficacy and tolerability of intravenous ibandronate injections in postmenopausal Osteoporosis: 2-year results from the DIVA study.
- The pro-osteogenic action of beta-catenin requires interaction With BMP signaling, but not Tcf/Lef transcriptional activity.
- The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans.
- Maintaining the trust of physicians and the public in the medical literature: report of a task force on scientific publishing of clinical trials.
- Safety considerations With bisphosphonates for the treatment of osteoporosis.
- Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks.
- Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment.
- Effects of dietary Calcium compared with Calcium supplements on estrogen metabolism and bone mineral density.
- Use of intravenous bisphosphonates in Osteoporosis.
- Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice.
- Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment.
- Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice With an osteoblast-specific deletion of connexin43.
- Role of connexin43 in osteoblast response to physical load.
- Intravenous ibandronate injections in postmenopausal women With osteoporosis: one-year results from the dosing intravenous administration study.
- Weightlessness and skeleton homeostasis.
- Gap junctions in skeletal development and function.
- Dominant negative N-cadherin inhibits osteoclast differentiation by interfering With beta-catenin regulation of RANKL, independent of cell-cell adhesion.
- A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
- Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass.
- A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.
- Cell-cell interactions in regulating osteogenesis and osteoblast function.
- Increased prevalence of celiac disease and need for routine screening among patients With osteoporosis.
- Cell-to-cell interactions in bone.
- Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation.
- Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription.
- Heterogeneous nuclear ribonucleoprotein K represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter.
- The oxidative Metabolism of estrogen modulates response to ERT/HRT in postmenopausal women.
- Estrogen and/or Calcium plus vitamin D increase mandibular bone mass.
- Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenoType: validation of an in vitro model for human bone marrow-derived pri...
- Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis.
- Development of mice With osteoblast-specific connexin43 gene deletion.
- Risedronate rapidly reduces the risk for nonvertebral fractures in women With postmenopausal osteoporosis.
- Genomic approaches to identifying transcriptional regulators of osteoblast differentiation.
- Gap junctional communication modulates gene transcription by altering the recruitment of Sp1 and Sp3 to connexin-response elements in osteoblast promoters.
- The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy.
- Activation of L-type Calcium channels is required for gap junction-mediated intercellular Calcium signaling in osteoblastic cells.
- Sequence and structure of the mouse connexin45 gene.
- Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.
- Proliferation, differentiation and apoptosis in connexin43-null osteoblasts.
- Connexin45 interacts With zonula occludens-1 in osteoblastic cells.
- Relationships between clinical attachment level and spine and hip bone mineral density: data from healthy postmenopausal women.
- Intercellular Calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors.
- Connexin45 interacts With zonula occludens-1 and connexin43 in osteoblastic cells.
- The oxidative Metabolism of estradiol conditions postmenopausal bone density and bone loss.
- A dominant negative cadherin inhibits osteoblast differentiation.
- Connexin43 Deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction.
- Alveolar bone height and postcranial bone mineral density: negative effects of cigarette smoking and parity.
- Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways.
- Human osteoblastic cells propagate intercellular Calcium signals by two different mechanisms.
- Comparison of morphological measurements extracted from digitized dental radiographs With lumbar and femoral bone mineral density measurements in postmenopausal women.
- Differential regulation of cadherins by dexamethasone in human osteoblastic cells.
- Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells.
- Low-frequency acoustic sweep monitoring of bone integrity and Osteoporosis.
- Age-related decline of bone mass and intestinal Calcium absorption in normal males.
- Gap junctional communication modulates gene expression in osteoblastic cells.
- Management of postmenopausal Osteoporosis for primary care.
- Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation.
- Cyclic stretch enhances gap junctional communication between osteoblastic cells.
- Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells.
- Attachment loss With postmenopausal age and smoking.
- ATP- and gap junction-dependent intercellular Calcium signaling in osteoblastic cells.
- In vitro and in vivo effects of ipriflavone on bone formation and bone biomechanics.
- An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats.
- Ipriflavone does not alter bone apatite crystal structure in adult male rats.
- Endocrine and physical determinants of bone mass in late postmenopause.
- The role of vitamin D metabolites in the treatment of Osteoporosis.
- Desensitization of Calcium messenger system in parathyroid hormone-stimulated opossum kidney cells.
- Connexin43 mediates direct intercellular communication in human osteoblastic cell networks.
- The 1992 John M. Kinney International Award for Nutrition and Metabolism. Dietary L-lysine and Calcium metabolism in humans: background.
- Activation of the Ca2+ message system by parathyroid hormone is dependent on the cell cycle.
- Interleukin-4 inhibits bone resorption and acutely increases cytosolic Ca2+ in murine osteoclasts.
- Estrogen status and bone mass in the premenopausal period: is Osteoporosis a developmental disease?
- Connexin43 and connexin45 form gap junctions With different molecular permeabilities in osteoblastic cells.
- Estrogen action on the bone mass of postmenopausal women is dependent on body mass and initial bone density.
- Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites.
- Poly-ADP-ribosylation-mediated degradation of ARTD1 by the NLRP3 inflammasome is a prerequisite for osteoclast maturation.
Conditions Treated
- Calcium Metabolism Disorders
- Diabetes Mellitus, Secondary
- Diabetes Type 2
- Diabetes With Renal Manifestations
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Elected Member
- Fuller Albright Award
- Kappa Delta Award
- CMS Meaningful Use Stage 1 Certification
Education
-
Barnes-Jewish Hospital
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1194743872 | |
| NPPES Provider LastName | CIVITELLI | |
| NPPES Provider FirstName | ROBERTO | |
| NPPES Provider ZIPCode | 631416300 | |
| NPPES Provider State | MO | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 213.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194743872 |
| Last Name Of The Provider | CIVITELLI |
| First Name Of The Provider | ROBERTO |
| View All |
Similar Doctors
|
|
Naga M. Yalla, MB BS
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen J. Giddings, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George T. Griffing, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Clutter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Natalya Rukhman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christy L. Richardson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sina A. Jasim, MD
This Doctor is OpenDoctor Recommended.
|